{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:30:12Z","timestamp":1790191812638,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008532","name":"Universidade Federal Do Rio Grande Do Norte","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008532","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to investigate the immunohistochemical expression of the Hippo pathway proteins LATS2 and YAP1 in oral tongue squamous cell carcinomas (OTSCCs) and normal oral mucosa (NOM), as well as potential relationships between them and clinicopathological characteristics and survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Twenty-six cases of OTSCC and 8 samples of NOM were analyzed. Clinical data were obtained from medical records. Morphological assessment was based on the WHO (2005) grading system and the combined score of tumor cell nests (B) and tumor invasion depth (D) (BD model). Immunoexpression of LATS2 and YAP1 was determined by immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In NOMs, LATS2 expression was observed across all epithelial layers, with nuclear predominance, whereas YAP1 was observed in the basal and parabasal layers. YAP1 expression was significantly higher in OTSCCs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and was significantly associated with the high-risk BD model (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034). OTSCCs with reduced LATS2 immunoexpression (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042) had poorer disease-free survival (DFS), while well-differentiated cases according to WHO presented better DFS outcome (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022). Multivariate analysis identified low LATS2 expression (HR 0.19; 95% CI 0.05\u20130.75;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017) and tumor size (HR 3.93; 95% CI 1.02\u201315.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046) as independent prognostic factors for 5-year DFS in OTSCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The functional alterations of LATS2 and YAP1 may reflect the dysregulation of the Hippo pathway in OTSCC, which possibly influences mechanisms of tumor progression and clinical behavior in this carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10006-026-01557-1","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:44:54Z","timestamp":1776138294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunoexpression profile of LATS2 and YAP1 and its clinicopathological relevance in oral tongue squamous cell carcinoma"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-0934","authenticated-orcid":false,"given":"Ondina Karla Mousinho","family":"Rocha Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-8882","authenticated-orcid":false,"given":"Andr\u00e9 Luis Alves","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3321-3689","authenticated-orcid":false,"given":"Lucas Melo","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-5904","authenticated-orcid":false,"given":"D\u00e9bora Frota","family":"Colares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-0147","authenticated-orcid":false,"given":"\u00c9ricka Janine Dantas","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-2566","authenticated-orcid":false,"given":"M\u00e1rcia Cristina Costa","family":"da Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"1557_CR1","doi-asserted-by":"publisher","first-page":"1440764","DOI":"10.3389\/fimmu.2024.1440764","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xie J, Wu H, Huang J, Zheng D, Wang S et al (2024) NK cell based immunotherapy against oral squamous cell carcinoma. Front Immunol 15:1440764. https:\/\/doi.org\/10.3389\/fimmu.2024.1440764","journal-title":"Front Immunol"},{"key":"1557_CR2","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.3390\/cimb46070402","volume":"46","author":"YN Park","year":"2024","unstructured":"Park YN, Ryu JK, Ju Y (2024) The potential MicroRNA diagnostic biomarkers in oral squamous cell carcinoma of the tongue. Curr Issues Mol Biol 46:6746\u20136756. https:\/\/doi.org\/10.3390\/cimb46070402","journal-title":"Curr Issues Mol Biol"},{"key":"1557_CR3","doi-asserted-by":"publisher","first-page":"e70493","DOI":"10.1002\/cam4.70493","volume":"13","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang Y, Li H, Liang Z, Zhou S, Pan J et al (2024) Prognostic implications of the number of lymph node metastases in oral tongue squamous cell carcinoma: a population study of the SEER database and an institutional registry. Cancer Med 13:e70493. https:\/\/doi.org\/10.1002\/cam4.70493","journal-title":"Cancer Med"},{"key":"1557_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/odi.14444","volume":"30","author":"\u00d3 Rapado-Gonz\u00e1lez","year":"2024","unstructured":"Rapado-Gonz\u00e1lez \u00d3, Costa-Fraga N, Bao-Caamano A, L\u00f3pez-Cedr\u00fan JL, \u00c1lvarez-Rodr\u00edguez R, Crujeiras AB et al (2024) Genome-wide DNA methylation profiling in tongue squamous cell carcinoma. Oral Dis 30:259\u2013271. https:\/\/doi.org\/10.1111\/odi.14444","journal-title":"Oral Dis"},{"key":"1557_CR5","doi-asserted-by":"publisher","first-page":"173657","DOI":"10.1016\/j.ejphar.2020.173657","volume":"890","author":"SA Mosaddad","year":"2021","unstructured":"Mosaddad SA, Beigi K, Doroodizadeh T, Haghnegahdar M, Golfeshan F, Ranjbar R et al (2021) Therapeutic applications of herbal\/synthetic\/bio-drug in oral cancer: an update. Eur J Pharmacol 890:173657. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173657","journal-title":"Eur J Pharmacol"},{"key":"1557_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/or.2020.7854","volume":"45","author":"J Wang","year":"2021","unstructured":"Wang J, Lv N, Lu X, Yuan R, Chen Z, Yu J (2021) Diagnostic and therapeutic role of microRNAs in oral cancer (Review). Oncol Rep 45:58\u201364. https:\/\/doi.org\/10.3892\/or.2020.7854","journal-title":"Oncol Rep"},{"key":"1557_CR7","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.3390\/ijms252312868","volume":"25","author":"H Yang","year":"2024","unstructured":"Yang H, Yang J, Zheng X, Chen T, Zhang R, Chen R et al (2024a) The Hippo pathway in breast cancer: the extracellular matrix and hypoxia. Int J Mol Sci 25:12868. https:\/\/doi.org\/10.3390\/ijms252312868","journal-title":"Int J Mol Sci"},{"key":"1557_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/cancers13020318","volume":"13","author":"R Zeng","year":"2021","unstructured":"Zeng R, Dong J (2021) The Hippo signaling pathway in drug resistance in cancer. Cancers (Basel) 13:318. https:\/\/doi.org\/10.3390\/cancers13020318","journal-title":"Cancers (Basel)"},{"key":"1557_CR9","doi-asserted-by":"publisher","first-page":"1247625","DOI":"10.3389\/fmed.2024.1247625","volume":"11","author":"Y Amano","year":"2024","unstructured":"Amano Y, Matsubara D, Kihara A, Yoshimoto T, Fukushima N, Nishino H et al (2024) The significance of Hippo pathway protein expression in oral squamous cell carcinoma. Front Med (Lausanne) 11:1247625. https:\/\/doi.org\/10.3389\/fmed.2024.1247625","journal-title":"Front Med (Lausanne)"},{"key":"1557_CR10","doi-asserted-by":"publisher","first-page":"1480701","DOI":"10.3389\/fimmu.2024.1480701","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Shao D, Gao X, Zhao P, Kong F, Deng J et al (2024) TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma. Front Immunol 15:1480701. https:\/\/doi.org\/10.3389\/fimmu.2024.1480701","journal-title":"Front Immunol"},{"key":"1557_CR11","volume-title":"Pathology and genetics of head and neck tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson J, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. IARC, Lyon"},{"key":"1557_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijom.2014.10.004","volume":"44","author":"A Almangush","year":"2014","unstructured":"Almangush A (2014) A simple novel prognostic model for early-stage oral tongue cancer. Int J Oral Maxillofac Surg 44:143\u2013150","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1557_CR13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.7150\/ijms.29995","volume":"16","author":"S Ono","year":"2019","unstructured":"Ono S, Nakano K, Takabatake K, Kawai H, Nagatsuka H (2019) Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma. Int J Med Sci 16:766\u2013773. https:\/\/doi.org\/10.7150\/ijms.29995","journal-title":"Int J Med Sci"},{"key":"1557_CR14","doi-asserted-by":"publisher","first-page":"104738","DOI":"10.1016\/j.critrevonc.2025.104738","volume":"211","author":"T Braun","year":"2025","unstructured":"Braun T, Bisht A, Zhu C, Idrees M, Alabeedi F, Kujan O (2025) Diagnostic, prognostic, and metastatic value of chemokines as biomarkers for oral squamous cell carcinoma and their precursor lesions - a systematic review. Crit Rev Oncol Hematol 211:104738. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104738","journal-title":"Crit Rev Oncol Hematol"},{"key":"1557_CR15","doi-asserted-by":"publisher","first-page":"1610471","DOI":"10.3389\/fcell.2025.1610471","volume":"13","author":"P Yang","year":"2025","unstructured":"Yang P, Li S (2025) Atypical Hippo signaling network: uncovering novel insights into head and neck cancer biology and advancements in precision intervention. Front Cell Dev Biol 13:1610471. https:\/\/doi.org\/10.3389\/fcell.2025.1610471","journal-title":"Front Cell Dev Biol"},{"key":"1557_CR16","doi-asserted-by":"publisher","unstructured":"Zhang Y, Hu CF, Chen J, Yan LX, Zeng YX, Shao JY (2010) LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis. BMC cancer 10:538. https:\/\/doi.org\/10.1186\/1471-2407-10-538","DOI":"10.1186\/1471-2407-10-538"},{"key":"1557_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1159\/000495495","volume":"51","author":"LL Han","year":"2018","unstructured":"Han LL, Yin XR, Zhang SQ (2018) MiR-650 promotes the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by directly inhibiting LATS2 expression. Cell Physiol Biochem 51:1179\u20131192. https:\/\/doi.org\/10.1159\/000495495","journal-title":"Cell Physiol Biochem"},{"key":"1557_CR18","doi-asserted-by":"publisher","first-page":"11648","DOI":"10.1080\/21655979.2021.1996513","volume":"12","author":"C Zhao","year":"2021","unstructured":"Zhao C, Chen J, Liu Y, Ju S, Wang G, Wang X (2021) Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer. Bioengineered 12:11648\u201311661. https:\/\/doi.org\/10.1080\/21655979.2021.1996513","journal-title":"Bioengineered"},{"key":"1557_CR19","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1016\/j.cell.2024.09.046","volume":"187","author":"K Punovuori","year":"2024","unstructured":"Punovuori K, Bertillot F, Miroshnikova YA, Binner MI, Myllym\u00e4ki SM, Follain G et al (2024) Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer. Cell 187:7267\u20137284e20. https:\/\/doi.org\/10.1016\/j.cell.2024.09.046","journal-title":"Cell"},{"key":"1557_CR20","doi-asserted-by":"publisher","first-page":"e011851","DOI":"10.1136\/jitc-2025-011851","volume":"13","author":"N Zwing","year":"2025","unstructured":"Zwing N, von Voith L, Alberti L, Gabriel SM, Monn\u00e9 Rodriguez JM, Feddersen R et al (2025) Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis. J Immunother Cancer 13:e011851. https:\/\/doi.org\/10.1136\/jitc-2025-011851","journal-title":"J Immunother Cancer"},{"key":"1557_CR21","doi-asserted-by":"publisher","first-page":"eaay3324","DOI":"10.1126\/sciadv.aay3324","volume":"6","author":"H Omori","year":"2020","unstructured":"Omori H, Nishio M, Masuda M, Miyachi Y, Ueda F, Nakano T et al (2020) YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Sci Adv 6:eaay3324. https:\/\/doi.org\/10.1126\/sciadv.aay3324","journal-title":"Sci Adv"},{"key":"1557_CR22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/pros.24226","volume":"81","author":"T Matsuda","year":"2021","unstructured":"Matsuda T, Miyata Y, Nakamura Y, Otsubo A, Mukae Y, Harada J et al (2021) Pathological significance and prognostic role of LATS2 in prostate cancer. Prostate 81:1252\u20131260. https:\/\/doi.org\/10.1002\/pros.24226","journal-title":"Prostate"},{"key":"1557_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5114\/pjp.2019.90395","volume":"70","author":"SH Jang","year":"2019","unstructured":"Jang SH, Oh MH, Cho H, Lee JH, Lee H, Ahn H et al (2019) Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma. Pol J Pathol 70:189\u2013197. https:\/\/doi.org\/10.5114\/pjp.2019.90395","journal-title":"Pol J Pathol"},{"key":"1557_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/1878-0261.13177","volume":"16","author":"US Ahmad","year":"2022","unstructured":"Ahmad US, Parkinson EK, Wan H (2022) Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. Mol Oncol 16:1625\u20131649. https:\/\/doi.org\/10.1002\/1878-0261.13177","journal-title":"Mol Oncol"},{"key":"1557_CR25","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.3390\/ijms26073147","volume":"26","author":"F Yang","year":"2025","unstructured":"Yang F, Zhou Y, Zhang Y, Wei W, Huang F, Yang D et al (2025) PDLIM3 regulates migration and invasion of head and neck squamous cell carcinoma via YAP-mediated epithelial-mesenchymal transition. Int J Mol Sci 26:3147. https:\/\/doi.org\/10.3390\/ijms26073147","journal-title":"Int J Mol Sci"},{"key":"1557_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/odi.13671","volume":"28","author":"A Wahab","year":"2022","unstructured":"Wahab A, Onkamo O, Pirinen M, Almangush A, Salo T (2022) The budding and depth of invasion model in oral cancer: a systematic review and meta-analysis. Oral Dis 28:275\u2013283. https:\/\/doi.org\/10.1111\/odi.13671","journal-title":"Oral Dis"},{"key":"1557_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s12276-020-00492-9","volume":"52","author":"E Shin","year":"2020","unstructured":"Shin E, Kim J (2020) The potential role of YAP in head and neck squamous cell carcinoma. Exp Mol Med 52:1264\u20131274. https:\/\/doi.org\/10.1038\/s12276-020-00492-9","journal-title":"Exp Mol Med"},{"key":"1557_CR28","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1111\/cas.14546","volume":"111","author":"J Li","year":"2020","unstructured":"Li J, Shi C, Zhou R, Han Y, Xu S, Ma H et al (2020) The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma. Cancer Sci 111:3222\u20133235. https:\/\/doi.org\/10.1111\/cas.14546","journal-title":"Cancer Sci"},{"key":"1557_CR29","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.3390\/ijms26093943","volume":"26","author":"S Yanar","year":"2025","unstructured":"Yanar S, Bal Albayrak MG, Korak T, Deveci Ozkan A, Arabac\u0131 Tamer S, Kasap M (2025) Targeting the Hippo pathway in breast cancer: a proteomic analysis of yes-associated protein inhibition. Int J Mol Sci 26:3943. https:\/\/doi.org\/10.3390\/ijms26093943","journal-title":"Int J Mol Sci"},{"key":"1557_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-024-02979-z","volume":"43","author":"Q Yang","year":"2024","unstructured":"Yang Q, Lv Z, Wang M, Kong M, Zhong C, Gao K et al (2024b) LATS1\/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression. J Exp Clin Cancer Res 43:54. https:\/\/doi.org\/10.1186\/s13046-024-02979-z","journal-title":"J Exp Clin Cancer Res"},{"key":"1557_CR31","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells11081370","volume":"11","author":"F Faraji","year":"2022","unstructured":"Faraji F, Ramirez SI, Anguiano Quiroz PY, Mendez-Molina AN, Gutkind JS (2022) Genomic Hippo pathway alterations and persistent YAP\/TAZ activation: new hallmarks in head and neck cancer. Cells 11:1370. https:\/\/doi.org\/10.3390\/cells11081370","journal-title":"Cells"},{"key":"1557_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/odi.14350","volume":"30","author":"JP Rodrigo","year":"2024","unstructured":"Rodrigo JP, Rodr\u00edguez-Santamarta T, Corte D, Garc\u00eda-de-la-Fuente V, Rodr\u00edguez-Torres N, Lequerica-Fern\u00e1ndez P et al (2024) Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: a retrospective cohort study. Oral Dis 30:149\u2013162. https:\/\/doi.org\/10.1111\/odi.14350","journal-title":"Oral Dis"},{"key":"1557_CR33","doi-asserted-by":"publisher","first-page":"217467","DOI":"10.1016\/j.canlet.2025.217467","volume":"612","author":"K Sato","year":"2025","unstructured":"Sato K, Faraji F, Cervantes-Villagrana RD, Wu X, Koshizuka K, Ishikawa T et al (2025) Targeting YAP\/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma. Cancer Lett 612:217467. https:\/\/doi.org\/10.1016\/j.canlet.2025.217467","journal-title":"Cancer Lett"},{"key":"1557_CR34","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.ceb.2025.102476","volume":"93","author":"SW Chan","year":"2025","unstructured":"Chan SW, Ong C, Hong W (2025) The recent advances and implications in cancer therapy for the hippo pathway. Curr Opin Cell Biol 93:102476. https:\/\/doi.org\/10.1016\/j.ceb.2025.102476","journal-title":"Curr Opin Cell Biol"},{"key":"1557_CR35","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s44318-024-00085-6","volume":"43","author":"O Jung","year":"2024","unstructured":"Jung O, Baek MJ, Wooldrik C, Johnson KR, Fisher KW, Lou J et al (2024) Nuclear phosphoinositide signaling promotes YAP\/TAZ-TEAD transcriptional activity in breast cancer. EMBO J 43:1740\u20131769. https:\/\/doi.org\/10.1038\/s44318-024-00085-6","journal-title":"EMBO J"},{"key":"1557_CR36","doi-asserted-by":"publisher","first-page":"114847","DOI":"10.1016\/j.ejmech.2022.114847","volume":"244","author":"M Luo","year":"2022","unstructured":"Luo M, Xu Y, Chen H, Wu Y, Pang A, Hu J et al (2022) Advances of targeting the YAP\/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. Eur J Med Chem 244:114847. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114847","journal-title":"Eur J Med Chem"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-026-01557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-026-01557-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-026-01557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:45Z","timestamp":1781647125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-026-01557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1007\/s10006-026-01557-1","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. A statement that the privacy rights of human subjects have been observed is also included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics statement\n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Committee of the Federal University of Rio Grande do Norte (Approval No. 5,288,936).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"70"}}